James Kovacic

James Kovacic

Auto-generated profile, based on publicly available information

James Kovacic

North Shore Urology Research Group, Sydney, Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2023 in BJU International
Verified
Journal Article
Closed access
JKJames Kovacic
James Kovacic
ACAshan Canagasingham
Ashan Canagasingham
WZWenjie Zhong
Wenjie Zhong
KLKathleen Lockhart
Kathleen Lockhart
ADAnkur Dhar
Ankur Dhar
ACAmanda Chung
Amanda Chung

25 November 2022 in Urology Case Reports
Verified
Journal Article
Open access
JKJames Kovacic
James Kovacic
MLMark Louie-Johnsun
Mark Louie-Johnsun
Here we present a rare case of a large co-secreting adrenocortical oncocytoma undergoing laparoscopic retroperitoneal-to-open removal. Our case was referred for surgical opinion as a result of a left suprarenal mass being identified as part of a work-up for new onset hirsutism and post-menopausal bleeding. We provide example of our surgical approach as well as discussion on this unique adrenal tumour variant.

11 April 2025 in Current Urology
Verified
Journal Article
Open access
JKJames Kovacic
James Kovacic
ADAnkur Dhar
Ankur Dhar
JKJonathan Kam
Jonathan Kam
ASAndrew Shepherd
Andrew Shepherd
AGAhmed Goolam
Ahmed Goolam
MWMatthew Winter
Matthew Winter
Objectives: To describe the surgical approach and perioperative outcomes of a multicenter series evaluating a robotic-assisted approach to radical cystectomy with total intracorporeal urinary diversion in the setting of prior pelvic radiotherapy. Materials and methods: We analyzed our prospective cystectomy database for patients who underwent robotic-assisted radical cystectomy for bladder cancer after radiotherapy between 2018 and 2022. Demographic information and data regarding preoperative factors including stage of disease, preoperative hydronephrosis, and history of pelvic radiotherapy were collected via review of electronic medical records. All operations were performed by 1 of 2 experienced urologists using the da Vinci X, Xi, or Si surgical platforms. Results: Ten patients were identified for this study. The median age of participants was 73.5 years (range, 41–84 years). The median American Society of Anesthesiologists classification score was 3 (range, 3–4). The median Charlson Comorbidity Index was 6 (range, 2–12). Among the patients, 4 out of 10 patients (40%) had muscle invasive bladder cancer before salvage surgery. Intracorporeal ileal conduit urinary diversion was performed in 8 patients, whereas 2 patients underwent intracorporeal neobladder formation. Median intraoperative blood loss was 250 mL (range, 150–600 mL), and median operative duration was 390 minutes (range, 195–450 minutes). The overall 30-day complication rate was 60% with a Clavien-Dindo grade ≥3 complication rate of 15%. Perioperative mortality was 0%. Median duration of follow-up was 210 days (range, 60–1580 days). Conclusions: This series describing the outcomes of salvage robotic-assisted radical cystectomy using total intracorporeal urinary diversion demonstrates the safety of this technique. Further studies with long-term follow-up, including oncological outcomes, are required to support the widespread adoption of this procedure.

4 June 2020 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JKJames L. Kovacic
James L. Kovacic
LALucy P. Aitchison
Lucy P. Aitchison
JIJulian C. Y. Ip
Julian C. Y. Ip

10 June 2022 in Journal of Urological Surgery
Verified
Journal Article
Closed access
JKJames Kovacic
James Kovacic
ELEdward Latif
Edward Latif

1 September 2023 in Journal of Urological Surgery
Verified
Journal Article
Open access
PKPaul Kim
Paul Kim
JKJames Lee Kovacic
James Lee Kovacic
ADAnkur Dhar
Ankur Dhar
ASAndrew Shepherd
Andrew Shepherd
MWMatthew Wayne Winter
Matthew Wayne Winter